Website in archive mode. Questions? Email [email protected]

  Gilead Sciences Inc ( GILD ) |
1996 - 2021 (26 years)

Net Revenue (Sales) is 
$26.5B (1Y +9.78% )

GILD Stock Price & Net Revenue (Sales)

Net Revenue (Sales) for GILD competitors.
AMGN ALXN CELG VRTX ILMN BIIB JNJ LLY MRK ABBV
Note: Stonk = Stock. Both words are used interchangeably. 🙂

Historical (All-Time) Stats for Net Revenue (Sales)

chevron_right 2021 $13.8B +422x
( +26.2% / year avg)
chevron_left 1996 $32.7M
vertical_align_top Peak $31.6B +1048x
vertical_align_bottom Bottom $30.1M
arrow_drop_up # Up Years 21 21 of 26
years up.
arrow_drop_down # Down Years 5
Up Years = Positive (0%+) YoY change
Down Years = Zero or Negative (0% or less) YoY change

Key Points (Stonk Price Comparison)

  • GILD's stock price has rallied +11,793% from $0.56 in 1996 , or +0.28x the rate relative to it's net revenue (sales) over the same period.
  • If GILD grows it's stock at the same rate as it's net revenue (sales) (+26.2%/year) , it's stock price will grow +1,024% and hit $679.78 over the next 10 years.
  • GILD's stock price has gone up 16 of the 21 years (+76%) it's net revenue (sales) were also up.
5-Year Change 🚀
-17.6%$25.7BNet Revenue (Sales)
+14.1%$5.4BCost of Revenue (Sales)
-23.3%$20.2BGross Profit Margin
-6.95%3.15Gross Profit Margin Ratio
-16.6%$4.2BResearch and Development (R&D)
-555.6%-$1.5BOther Income/Expenses, Net
+8.21%$8.4BTotal Operating Expenses
+10.4%$13.9BCost & Expenses
+11.7%$1.0BInterest Expense/Income, Net
-72.4%$312.0MDepreciation & Amortization (D&A)
-38.6%$12.1BEBITDA
-36.5%$11.8BOperating Income
-632.1%-$1.7BTotal Other Income/Expenses
-49.7%$9.1BPretax Income (Earnings)
-39.0%1.41Pretax Income (Earnings) Margin
-42.0%$2.2BProvision For Income Taxes
-51.5%$6.9BNet Income (Earnings)
-46.5%5.52Earnings Per Share (EPS)
-45.8%5.48Earnings Per Share (EPS) Diluted
-9.18%$5.0BShares Outstanding
-10.6%$5.0BShares Outstanding (Diluted)
  • Line Item (in $M) FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000 FY 1999 FY 1998 FY 1997
    1 Revenue 24689000000 22449000000 22127000000 26107000000 30390000000 32639000000 24890000000 11201688000 9702517000 8385385000 7949420000 7011383000 5335750000 4230045000 3026139000 2028400000 1324621000 867864000 466790000 233769000 195555000 169000000 32600000 40000000
    2 Cost of Revenue 4572000000.00 4675000000.00 4853000000.00 4371000000.00 4261000000.00 4006000000.00 3788000000.00 2858502000.00 2471363000.00 2124410000.00 1869876000.00 1595558000.00 1127246000.00 768771000.00 433320000.00 260326000.00 166587000.00 112691000.00 69724000.00 43764000.00 21504000.00 16900000.00 -2200000.00 -1800000.00
    3 Gross Profit (Income) 20117000000 17774000000 17274000000 21736000000 26129000000 28633000000 21102000000 8343186000 7231154000 6260975000 6079544000 5415825000 4208504000 3461274000 2592819000 1768074000 1158034000 755173000 397066000 190005000 174051000 152100000 34800000 41800000
    4 R&D 5039000000 9106000000 5018000000 3734000000 5098000000 3014000000 2854000000 2119756000 1759945000 1229151000 1072930000 939918000 721768000 591026000 383861000 277724000 223552000 164873000 134758000 185553000 131568000 112900000 75300000 59200000
    5 SG&A 5151000000 4381000000 4056000000 3878000000 3398000000 3426000000 2983000000 1699431000 1461034000 1241983000 1044392000 946686000 797344000 705741000 573660000 379248000 302793000 250157000 181301000 125141000 82793000 78300000 31000000 25500000
    6 Other Expenses -1418000000.00 1868000000.00 676000000.00 523000000.00 428000000.00 154000000.00 3000000.00 -8886000.00 -37279000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    7 Operating Expenses 10190000000 13487000000 9074000000 7612000000 8496000000 6440000000 5837000000 3819187000 3220979000 2471134000 2117322000 1886604000 1519112000 1296767000 957521000 656972000 526345000 425249000 316059000 310694000 226369000 203800000 109100000 87700000
    8 Interest Expense 984000000.00 995000000.00 1077000000.00 1118000000.00 964000000.00 688000000.00 412000000.00 306894000.00 360916000.00 205418000.00 108961000.00 69662000.00 12101000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    9 D&A 1480000000.00 1404000000.00 1429000000.00 1286000000.00 1158000000.00 1098000000.00 1050000000.00 344704000.00 278206000.00 302232000.00 265477000.00 212944000.00 102467000.00 51279000.00 47284000.00 35777000.00 24408000.00 20859000.00 14428000.00 14691000.00 12008000.00 12600000.00 2800000.00 3000000.00
    10 EBITDA 11407000000 5691000000 9629000000 15410000000 18791000000 23291000000 16315000000 4868703000 4288381000 4092073000 4227699000 3742165000 2791859000 2215786000 1682582000 1146879000 656097000 350783000 95435000 -105998000 -40310000 -39100000 -71500000 -42900000
    11 Operating Income 9927000000 4287000000 8200000000 14124000000 17633000000 22193000000 15265000000 4523999000 4010175000 3789841000 3962222000 3529221000 2689392000 2164507000 1635298000 1111102000 631689000 329924000 81007000 -120689000 -52318000 -51700000 -74300000 -45900000
    12 Other Income Expenses (Net) -7274000000.00 1868000000.00 676000000.00 523000000.00 428000000.00 154000000.00 3000000.00 -8886000.00 -37279000.00 0.00 0.00 0.00 -10851000.00 0.00 -2394051000.00 0.00 13138000.00 -498818000.00 -16048000.00 164395000.00 -2858000.00 -23800000.00 18400000.00 18300000.00
    13 Pre-Income Tax 1669000000.00 5160000000.00 7799000000.00 13529000000.00 17097000000.00 21659000000.00 14856000000.00 4208219000.00 3611980000.00 3651004000.00 3913548000.00 3501956000.00 2734405000.00 2270338000.00 -638207000.00 1161792000.00 656422000.00 -167533000.00 73397000.00 57447000.00 -41907000.00 -65600000.00 0.00 0.00
    14 Income Tax Expense 1580000000.00 -204000000.00 2339000000.00 8885000000.00 3609000000.00 3553000000.00 2797000000.00 1150933000.00 1038381000.00 861945000.00 1023799000.00 876364000.00 723251000.00 655040000.00 551750000.00 347878000.00 207051000.00 -95530000.00 1300000.00 4135000.00 1199000.00 900000.00 0.00 0.00
    15 Net Income 123000000 5386000000 5455000000 4628000000 13501000000 18108000000 12101000000 3074808000 2591566000 2803637000 2901257000 2635755000 2011154000 1615298000 -1189957000 813914000 449371000 -72003000 72097000 52271000 -56776000 -66500000 -56100000 -28000000
    16 EPS 0.10 4.24 4.20 3.54 10.08 12.37 7.95 2.01 1.71 1.81 1.70 1.46 1.09 0.87 -0.65 0.45 0.26 -0.04 0.05 0.04 -0.04 -0.05 -0.06 -0.03
    17 EPS Diluted 0.10 4.22 4.17 3.51 9.94 11.91 7.35 1.81 1.64 1.77 1.66 1.41 1.05 0.84 -0.65 0.43 0.25 -0.04 0.04 0.03 -0.04 -0.05 -0.06 -0.03
    18 Shares Outstanding 1255000000 1270000000 1298000000 1307000000 1339000000 1464000000 1522000000 1528620000 1514621000 1549806000 1712120000 1809208000 1841386000 1858266000 1836424000 1817356000 1728000000 1608840000 1564344000 1521960000 1456800000 1370432000 971616000 938432000
    19 Shares Outstanding (Diluted) 1255000000 1277000000 1308000000 1319000000 1358000000 1521000000 1647000000 1694747000 1582549000 1580236000 1746792000 1868218000 1917650000 1928712000 1836424000 1897136000 1856984000 1608840000 1651816000 1618568000 1456800000 1370432000 971616000 938432000
  • Line Item (in $M) FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000 FY 1999 FY 1998 FY 1997
    1 Cash & Cash Equivalents 5997000000 11631000000 17940000000 7588000000 8229000000 12851000000 10027000000 2112806000 1803694000 9883777000 907879000 1272958000 1459302000 968086000 816007000 707913000 280909000 194719000 616931000 162339000 197292000 47000000 32500000 32000000
    2 Short Term Investments 1411000000.00 12721000000.00 12149000000.00 17922000000.00 3666000000.00 1756000000.00 101000000.00 18756000.00 58556000.00 16491000.00 1190789000.00 384017000.00 330760000.00 203892000.00 120844000.00 1615972000.00 973129000.00 512281000.00 325443000.00 420512000.00 315586000.00 247400000.00 0.00 0.00
    3 Cash & S-T Investments 7408000000 24352000000 30089000000 25510000000 11895000000 14607000000 10128000000 2131562000 1862250000 9900268000 2098668000 1656975000 1790062000 1171978000 936851000 2323885000 1254038000 707000000 942374000 582851000 512878000 294400000 32500000 32000000
    4 Accounts Receivables 4892000000.00 3582000000.00 3327000000.00 3851000000.00 4514000000.00 5854000000.00 4635000000.00 2100286000.00 1751388000.00 1951167000.00 1621966000.00 1389534000.00 1023397000.00 795127000.00 609320000.00 396125000.00 371245000.00 235217000.00 175036000.00 74228000.00 48814000.00 45600000.00 0.00 0.00
    5 Inventory 1683000000.00 922000000.00 814000000.00 801000000.00 1587000000.00 1955000000.00 1386000000.00 2055788000.00 1744982000.00 1389983000.00 1203809000.00 1051771000.00 927868000.00 599966000.00 564145000.00 216903000.00 135991000.00 98102000.00 51628000.00 39280000.00 20562000.00 21000000.00 0.00 0.00
    6 Other Current Assets 2013000000.00 0.00 0.00 0.00 1062000000.00 506000000.00 472000000.00 91925000.00 0.00 126846000.00 116244000.00 66891000.00 126066000.00 35242000.00 22863000.00 22073000.00 0.00 0.00 0.00 0.00 11544000.00 11000000.00 255800000.00 308300000.00
    7 Total Current Assets 15996000000 30296000000 35836000000 31823000000 20445000000 24763000000 17714000000 7273753000 6156347000 13918785000 5708082000 4812558000 4300281000 3028292000 2429206000 3092208000 1849694000 1265898000 1183760000 707759000 593798000 372000000 288300000 340300000
    8 PP&E 4967000000.00 4502000000.00 4006000000.00 3295000000.00 2865000000.00 2276000000.00 1674000000.00 1166181000.00 1100259000.00 774406000.00 701235000.00 699970000.00 528799000.00 447696000.00 361299000.00 242568000.00 223106000.00 198200000.00 67727000.00 62828000.00 55174000.00 51400000.00 10200000.00 10300000.00
    9 Goodwill 8108000000.00 4117000000.00 4117000000.00 4159000000.00 1172000000.00 1172000000.00 1172000000.00 1169023000.00 1060919000.00 1004102000.00 1425592000.00 1524777000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    10 Intangible Assets 33126000000.00 13786000000.00 15738000000.00 17100000000.00 8971000000.00 10247000000.00 11073000000.00 11900106000.00 11736393000.00 1062864000.00 1425592000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    11 Goodwill & Intangible Assets 41234000000.00 17903000000.00 19855000000.00 21259000000.00 10143000000.00 11419000000.00 12245000000.00 13069129000.00 12797312000.00 2066966000.00 1425592000.00 1524777000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    12 L-T Investments 502000000.00 1488000000.00 1423000000.00 11184000000.00 20485000000.00 11601000000.00 1598000000.00 439000000.00 720000000.00 64000000.00 3219000000.00 2248000000.00 1450000000.00 1550000000.00 453000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    13 Tax Assets 0.00 0.00 0.00 0.00 402000000.00 324000000.00 236000000.00 154765000.00 131107000.00 144015000.00 153379000.00 101498000.00 283214000.00 297359000.00 302539000.00 66893000.00 45446000.00 52494000.00 0.00 0.00 0.00 0.00 0.00 0.00
    14 Other Non-Current Assets 5708000000.00 7438000000.00 2555000000.00 2722000000.00 2214000000.00 1056000000.00 731000000.00 195163000.00 159187000.00 160674000.00 181149000.00 85635000.00 199495000.00 2061369000.00 992937000.00 362982000.00 37717000.00 38130000.00 36696000.00 24199000.00 29127000.00 13400000.00 4400000.00 1500000.00
    15 Total Non-Current Assets 52411000000 31331000000 27839000000 38460000000 36532000000 27076000000 16950000000 15223032000 15083491000 3384349000 5884548000 4886001000 2718293000 2806424000 1656775000 672443000 306269000 288824000 104423000 87027000 84301000 64800000 14600000 11800000
    16 Other Assets 4799000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    17 Total Assets 68407000000 61627000000 63675000000 70283000000 56977000000 51839000000 34664000000 22496785000 21239838000 17303134000 11592630000 9698559000 7018574000 5834716000 4085981000 3764651000 2155963000 1554722000 1288183000 794786000 678099000 436800000 302900000 352100000
    18 Accounts Payables 844000000.00 713000000.00 790000000.00 814000000.00 1206000000.00 1178000000.00 955000000.00 1255914000.00 1327339000.00 1206052000.00 803025000.00 810544000.00 601200000.00 290333000.00 367029000.00 61083000.00 47552000.00 35649000.00 24406000.00 19174000.00 11605000.00 9500000.00 3400000.00 3300000.00
    19 S-T Debt 2757000000.00 2499000000.00 2748000000.00 2747000000.00 0.00 983000000.00 483000000.00 2697044000.00 1169490000.00 1572000.00 646345000.00 0.00 0.00 286000.00 18747000.00 60206000.00 181000.00 139000.00 194000.00 1492000.00 3034000.00 3200000.00 800000.00 1900000.00
    20 Income Tax Payables 5016000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    21 Deferred Revenue 0.00 0.00 0.00 0.00 202000000.00 440000000.00 134000000.00 110640000.00 103162000.00 74665000.00 103175000.00 122721000.00 42963000.00 30747000.00 17777000.00 18353000.00 19880000.00 5474000.00 7692000.00 3996000.00 0.00 0.00 0.00 0.00
    22 Other Current Liabilities 0.00 0.00 0.00 11635000000.00 9219000000.00 9891000000.00 5618000000.00 6325528000.00 4270020000.00 0.00 0.00 0.00 0.00 0.00 26654000.00 95739000.00 1000.00 0.00 0.00 0.00 43599000.00 35200000.00 27600000.00 28200000.00
    23 Total Current Liabilities 11397000000 9759000000 10605000000 11635000000 9219000000 9891000000 5761000000 6325421000 4270020000 2514790000 2464950000 1871631000 1220992000 736275000 764276000 455338000 253454000 185895000 104892000 80117000 58238000 47900000 31800000 33400000
    24 L-T Debt 28645000000.00 22094000000.00 24574000000.00 30795000000.00 26346000000.00 21195000000.00 11921000000.00 3938708000.00 7054555000.00 7605734000.00 2945598000.00 1242826000.00 1356442000.00 1311604000.00 1391847000.00 240650000.00 234000.00 345323000.00 595273000.00 250389000.00 252238000.00 84800000.00 600000.00 1300000.00
  • Line Item (in $M) FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010 FY 2009 FY 2008 FY 2007 FY 2006 FY 2005 FY 2004 FY 2003 FY 2002 FY 2001 FY 2000 FY 1999 FY 1998 FY 1997
    1 Net Income (Earnings) 123000000 5386000000 5455000000 4628000000 13501000000 18108000000 12101000000 3074808000 2591566000 2803637000 2901257000 2635755000 2011154000 1615298000 -1189957000 813914000 449371000 -72003000 72097000 52271000 -56776000 -66500000 -56100000 -28000000
    2 D&A 1480000000.00 1404000000.00 1429000000.00 1286000000.00 1158000000.00 1098000000.00 1050000000.00 344704000.00 278206000.00 302232000.00 265477000.00 212944000.00 102467000.00 51279000.00 47284000.00 35777000.00 24408000.00 20859000.00 14428000.00 14691000.00 12008000.00 12600000.00 2800000.00 3000000.00
    3 Deferred Income Tax -214000000.00 -2098000000.00 289000000.00 -82000000.00 67000000.00 193000000.00 248000000.00 186474000.00 73236000.00 101292000.00 12152000.00 -42013000.00 -4081000.00 133069000.00 -9220000.00 -53239000.00 151568000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    4 Stock-Based Compensation (SBC) 643000000.00 636000000.00 845000000.00 638000000.00 380000000.00 382000000.00 360000000.00 251984000.00 208725000.00 192378000.00 200041000.00 180684000.00 153364000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    5 Change in Working Capital -15938000000.00 -4694000000.00 5043000000.00 8962000000.00 -3646000000.00 2919000000.00 11004668000.00 -937995000.00 -9517668000.00 8160863000.00 302205000.00 -138362000.00 787272000.00 627087000.00 -971940000.00 1040630000.00 516237000.00 1135000.00 451226000.00 92082000.00 211460000.00 67600000.00 -50400000.00 22700000.00
    6 Accounts Receivables -1171000000.00 -218000000.00 480000000.00 754000000.00 1192000000.00 -1397000000.00 -2578000000.00 -315299000.00 197986000.00 -375736000.00 -348875000.00 -356462000.00 -257161000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    7 Inventory -195000000.00 -95000000.00 -310000000.00 -253000000.00 -488000000.00 -855000000.00 143000000.00 -343143000.00 -349924000.00 -200793000.00 -161190000.00 -75266000.00 -330726000.00 -34619000.00 -358184000.00 -81923000.00 -37889000.00 -46474000.00 -12348000.00 -18718000.00 397000.00 -4400000.00 0.00 0.00
    8 Accounts Payables 80000000.00 -61000000.00 -39000000.00 -430000000.00 47000000.00 226000000.00 -289000000.00 -97673000.00 117485000.00 428944000.00 -4453000.00 203641000.00 312568000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    9 Other Working Capital 4599000000 20537000000 25231000000 20188000000 11226000000 14872000000 11953000000 948332000 1886327000 11403995000 3243132000 2940927000 3079289000 2292017000 1664930000 2636870000 1596240000 1080003000 1078868000 627642000 535560000 324100000 256500000 306900000
    10 Other Non-Cash Items 6106000000.00 5330000000.00 876000000.00 304000000.00 408000000.00 -24000000.00 101000000.00 105989000.00 -1878000.00 47931000.00 92494000.00 152824000.00 189698000.00 201817000.00 200697000.00 0.00 0.00 0.00 611000.00 0.00 0.00 0.00 100000.00 -100000.00
    11 Net Cash Provided by Operating Activities 8168000000 9144000000 8400000000 11898000000 16669000000 20329000000 12818000000 3104988000 3194716000 3639010000 2833913000 3080054000 2204659000 1765398000 1218059000 715080000 511378000 234607000 74409000 -88132000 -38202000 -62600000 -46700000 -19900000
    12 Investments in PP&E 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -78648000.00 -105208000.00 -47951000.00 -51366000.00 -38609000.00 -17597000.00 -26329000.00 -15621000.00 -12500000.00 -2500000.00 -3900000.00
    13 Acquisitions (Net) -25742000000.00 -4251000000.00 0.00 -10426000000.00 0.00 0.00 0.00 -379000000.00 -10752000000.00 -589000000.00 -91000000.00 -1248000000.00 -11000000.00 -46000000.00 -2736000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    14 Purchase of Investments -20770000000 -32228000000 -10579000000 -23314000000 -25976000000 -17239000000 -2125000000 -256700000 -1269898000 -5127790000 -5502687000 -2614046000 -3273112000 -3507119000 -2609483000 -2225980000 -1464046000 -934759000 -490259000 -377725000 -229862000 -187000000 -486100000 -411000000
    15 Sales/Maturities of Investments 32718000000 29921000000 25858000000 18261000000 14739000000 5511000000 859000000 571772000 572525000 9438147000 3717820000 1876019000 3220149000 2329743000 3711529000 1582015000 1024584000 744530000 603678000 280534000 163730000 185600000 528600000 284900000
    16 Other Investing Activities -171000000.00 -4685000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -50000000.00 14300000.00 -2450000.00 -2400000.00 0.00 100000.00
    17 Net Cash used for Investing Activities -14615000000 -7817000000 14355000000 -16069000000 -11985000000 -12475000000 -1823000000 -254355000 -11846054000 3589845000 -1937751000 -2215900000 -178819000 -1302467000 -1739334000 -691916000 -490828000 -727345000 45822000 20780000 -84203000 -16300000 40000000 -129900000
    18 Debt Repayment -2500000000.00 -2750000000.00 -6250000000.00 -1811000000.00 -1981000000.00 -997000000.00 -4805000000.00 -4439968000.00 -1839325000.00 -651549000.00 -868408000.00 -311103000.00 -4326000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    19 Common Stock Issued 256000000.00 209000000.00 289000000.00 234000000.00 208000000.00 319000000.00 331000000.00 313079000.00 466283000.00 211737000.00 221223000.00 222728000.00 246125000.00 243427000.00 403386000.00 143283000.00 78796000.00 83806000.00 51386000.00 36311000.00 30451000.00 29300000.00 9000000.00 53200000.00
    20 Common Stock Repurchased -1583000000.00 -1749000000.00 -2900000000.00 -954000000.00 -11001000000.00 -10002000000.00 -5349000000.00 -582358000.00 -667041000.00 -2383132000.00 -4022593000.00 -998495000.00 -1969582000.00 -487543000.00 -544942000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    21 Dividends Paid -3449000000.00 -3222000000.00 -2971000000.00 -2731000000.00 -2455000000.00 -1874000000.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
    22 Other Financing Activities -138000000.00 -122000000.00 -486000000.00 -330000000.00 102000000.00 770000000.00 416000000.00 430599000.00 244840000.00 -74189000.00 213143000.00 -364568000.00 191939000.00 76276000.00 95259000.00 -1184000.00 0.00 0.00 0.00 0.00 0.00 0.00 100000.00 0.00
    23 Net Cash Used Provided by Financing Activities 770000000.00 -7634000000.00 -12318000000.00 3393000000.00 -9347000000.00 -4963000000.00 -3025000000.00 -2543941000.00 563346000.00 1763569000.00 -1338710000.00 -1051438000.00 -1535844000.00 -267299000.00 649261000.00 441896000.00 78659000.00 82091000.00 386609000.00 33550000.00 269045000.00 24000000.00 7200000.00 49800000.00
    24 Net Change in Cash -5634000000.00 -6309000000.00 10352000000.00 -641000000.00 -4622000000.00 2824000000.00 7914000000.00 309112000.00 -8080083000.00 8975898000.00 -365079000.00 -186344000.00 491216000.00 152079000.00 108094000.00 427004000.00 86190000.00 -422212000.00 493441000.00 -34953000.00 150281000.00 -54100000.00 0.00 0.00
  • About
    Industry: Drug Manufacturers General
    Sector: Healthcare
    Country: US
    IPO Date: 1/1/1992
    Stonk Exchange: NASDAQ
    • Gilead Sciences, Inc
    • is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need.
    • The company is headquartered in Foster City, California and currently employs 11,000 full-time employees.
    • The firm's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions.
    • Its products for HIV/AIDS patients include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada, Emtriva, Tybost and Vitekta.
    • Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera.
    • The company offers Zydelig to patients with hematology/oncology diseases.
    • Its products for patients with various cardiovascular diseases include Letairis, Ranexa and Lexiscan.
    • Its products for various inflammation/respiratory diseases include Cayston and Tamiflu.
    • The company had operations in more than 30 countries, as of December 31, 2016.



Looking for a specific stock? Please use our search ("TSLA, AAPL, SPY...") at the top. Otherwise, you can refer to the lists below.
List of all stocks by first letter/number.